Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating whether pentoxifylline can protect against doxorubicin-induced cardiotoxicity in breast cancer patients; r…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
The SIBYL study investigates therapy response assessment using liquid biopsy in cancer patients. The trial is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)
The update describes an ongoing clinical trial examining the biomechanics of radiotherapy and surgery in breast cancer patients, with recrui…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
An observational clinical trial update evaluating bone complications in post-menopausal breast cancer patients who have stopped denosumab an…
-
CLINICAL_TRIALS other · 2025-08-22Clinical Trial Update: Breast Cancer Prevention and Screening Membership [NA]
The trial NCT05258539 on breast cancer prevention and screening, sponsored by Assistance Publique - Hôpitaux de Paris, is currently active b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-08-21EMA Authorised: Trodelvy (sacituzumab govitecan) — Gilead Sciences Ireland UC
EMA authorised Sacituzumab govitecan (Trodelvy) for breast cancer, including triple-negative breast cancer, on 5 June 2025, with Gilead Scie…
-
FDA approval · 2025-08-21FDA Approved: TRAZIMERA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TRAZIMERA (trastuzumab-qyyp) from Pfizer Laboratories Div Pfizer Inc, authorizing changes under …
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of LY3039478 in participants with advanced or metastatic solid tumors was terminated. Results were posted on 2025-08-21.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: The Effects of Erector Spinae Plane Block on Pain Scores in Unilateral Breast Cancer Surgery [NA]
Completed clinical trial evaluating erector spinae plane block for postoperative pain in unilateral breast cancer surgery.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases [Phase 1, Phase 2]
Phase I/II study investigating intrathecal administration of trastuzumab deruxtecan (T-DXd) via Ommaya for HER2-expressing breast cancer wit…
-
CLINICAL_TRIALS other · 2025-08-21Clinical Trial Update: [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer [Phase 1]
A Phase 1 study of [177Lu]Lu-NeoB in combination with ribociclib and fulvestrant for ER-positive, HER2-negative, GRPR-positive advanced brea…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery [NA]
University of Michigan-led trial aims to de-implement low-value preoperative testing in patients undergoing low-risk surgeries and is curren…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating adebrelimab in combination with dalpiciclib and standard endocrine therapy for HR+/HER2- …
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]
A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Evaluation of Serum IL-7 as a Biomarker in Breast Cancer
A clinical trial is evaluating serum interleukin-7 as a biomarker in breast cancer. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel [Phase 2, Phase 3]
Phase 2/3 trial results indicate that routine pre-medications to prevent hypersensitivity reactions may be safely stopped for patients with …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer [Phase 4]
A Phase 4 clinical trial evaluating pulsed electromagnetic field therapy plus a tailored exercise program for chemotherapy-induced neuropath…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer [Phase 2]
Phase 2 clinical trial update investigating SHR-A1811 in combination with Pyrotinib for locally advanced or metastatic HER2-positive breast …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
This clinical trial investigates new gene expression profiles by linking MammaPrint and BluePrint data with full-genome data to correlate wi…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib [Phase 2]
This Phase 2 trial update describes using circulating tumor DNA in the blood to guide which patients with HR-positive, HER2-negative metasta…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
A clinical trial titled 'Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors' is currently recruiting. …
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence
A clinical trial led by Pontificia Universidad Catolica de Chile is evaluating intraoperative detection of breast cancer using electrosurgic…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer
This is a clinical trial update about intermittent treatment periods guided by ctDNA-MRD status in advanced HER2-positive breast cancer. The…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer [Phase 2]
This Phase 2 trial investigates the efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy as neoadjuvant treatment for HR…